臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 总笔数 :0
	造访人次 : 52806311 在线人数 : 596 教育部委托研究计画计画执行:国立台湾大学图书馆

搜寻范围

进阶搜寻

登入

管理

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"yen shen lu"的相关文件

回到依作者浏览
依题名排序	依日期排序

显示项目 66-75 / 149 (共15页)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
每页显示[10|25|50]项目

机构	日期	题名	作者
臺大學術典藏	2020-05-25T06:52:04Z	OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma	Cheng A.-L.;Kuo M.-L;Chen C.-S;Feng W.-C;Lee W.-C;Chen K.-F;Hsu C.-H;Yen-Shen Lu;Yeh P.Y;Gao M; Gao M; Yeh P.Y; YEN-SHEN LU; Hsu C.-H; Chen K.-F; Lee W.-C; Feng W.-C; Chen C.-S; Kuo M.-L; Cheng A.-L.
臺大學術典藏	2020-05-25T06:52:04Z	Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma	Cheng A.-L.;Hsu C;Yen-Shen Lu;Wang D.-S;Fan H.-H;Yu S.-L;Liou J.-Y;Liang J.-D;Shen Y.-C;Ou D.-L; Ou D.-L; Shen Y.-C; Liang J.-D; Liou J.-Y; Yu S.-L; Fan H.-H; Wang D.-S; YEN-SHEN LU; Hsu C; Cheng A.-L.
臺大學術典藏	2020-05-25T06:52:03Z	Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin	Cheng A.-L.; Lin C.-H; Chang K.-J; Kuo W.-H; Hsu C; Lee W.-C; Liau J.-Y; Huang C.-S; Shao Y.-Y;Kuo K.-T;Hu F.-C;Yen-Shen Lu;Huang C.-S;Liau J.-Y;Lee W.-C;Hsu C;Kuo W.-H;Chang K.-J;Lin C.-H;Cheng A.-L.; Shao Y.-Y; Kuo K.-T; Hu F.-C; YEN-SHEN LU
臺大學術典藏	2020-05-25T06:52:03Z	Locoregional therapy improves survival for metastatic breast cancer patients? Benefit remains questionable!	Yen-Shen Lu;Lin C.-H;Chang D.-Y; Chang D.-Y; Lin C.-H; YEN-SHEN LU
臺大學術典藏	2020-05-25T06:52:03Z	Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009	Pritchard K.I.;Shao Z.-M;Voravud N;Yen-Shen Lu;Yip C.H;Ang P.T;Khoo K.S;Anderson B.O;Wong N.S; Wong N.S; Anderson B.O; Khoo K.S; Ang P.T; Yip C.H; YEN-SHEN LU; Voravud N; Shao Z.-M; Pritchard K.I.
臺大學術典藏	2020-05-25T06:52:02Z	Unique features of breast cancer in Asian women-Breast cancer in Taiwan as an example	Huang C.-S;Lin C.-H;Yen-Shen Lu;Shen C.-Y.; Huang C.-S; Lin C.-H; YEN-SHEN LU; Shen C.-Y.
臺大學術典藏	2020-05-25T06:52:02Z	O6-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers	Wu P.-F;Kuo K.-T;Kuo L.-T;Lin Y.-T;Lee W.-C;Yen-Shen Lu;Yang C.-H;Wu R.-M;Tu Y.-K;Tasi J.-C;Tseng H.-M;Tseng S.-H;Cheng A.-L;Lin C.-H.; Wu P.-F; Kuo K.-T; Kuo L.-T; Lin Y.-T; Lee W.-C; YEN-SHEN LU; Yang C.-H; Wu R.-M; Tu Y.-K; Tasi J.-C; Tseng H.-M; Tseng S.-H; Cheng A.-L; Lin C.-H.
臺大學術典藏	2020-05-25T06:52:01Z	Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma	Chiang C.-T;Yeh P.-Y;Gao M;Chen C.-W;Yeh L.-C;Feng W.-C;Kuo S.-H;Hsu C.-H;Yen-Shen Lu;Cheng A.-L.; Chiang C.-T; Yeh P.-Y; Gao M; Chen C.-W; Yeh L.-C; Feng W.-C; Kuo S.-H; Hsu C.-H; YEN-SHEN LU; Cheng A.-L.
臺大學術典藏	2020-05-25T06:52:01Z	Management of ErbB2-positive breast cancer: Insights from preclinical and clinical studies with lapatinib	Vogel C;Chan A;Gril B;Kim S.-B;Kurebayashi J;Liu L;Yen-Shen Lu;Moon H.; Vogel C; Chan A; Gril B; Kim S.-B; Kurebayashi J; Liu L; YEN-SHEN LU; Moon H.
臺大學術典藏	2020-05-25T06:52:01Z	The prevalence and assessment of ErbB2-positive breast cancer in Asia: A literature survey	Tan Y.O;Han S;Yen-Shen Lu;Yip C.-H;Sunpaweravong P;Jeong J;Caguioa P.B;Aggarwal S;Yeoh E.M;Moon H.; Tan Y.O; Han S; YEN-SHEN LU; Yip C.-H; Sunpaweravong P; Jeong J; Caguioa P.B; Aggarwal S; Yeoh E.M; Moon H.

显示项目 66-75 / 149 (共15页)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
每页显示[10|25|50]项目